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Abstract 
Purpose: To evaluate the implementation of an Advanced Registered Nurse Practitioner (ARNP) – community pharmacist team-based 
collaborative model for managing hypertension in a rural, Midwestern, community pharmacy and family medicine clinic using the 
core functions of the patient centered medical home model (PCMH).   
Methods:  Thirteen patients with uncontrolled hypertension, 5 of who were newly diagnosed, were referred to the pharmacist by the 
ARNP.  The pharmacist rechecked the patient’s blood pressure (BP) every 2 weeks after referral and made drug therapy change 
recommendations to the ARNP if the patient was not below goal. 
Results:  Following the intervention, the average SBP and DBP decreased 24 mmHg and 12mmHg, respectively. The pharmacists 
made 21 recommendations (dose increase (11), add a medication (6), change a medication (2), and addition of an adherence tool 
(2)), 100% of which were accepted by the ARNP. 
Conclusion: A team-based approach to managing hypertension in a rural community pharmacy and family medicine clinic was an 
effective way to lower blood pressure.  In addition, the core functions of the PCMH model can be delivered in a small family medicine 
practice.  Creating specific expectations for each member of the team prior to referring patients improved the efficiency of the 
intervention.  
 
 
Background 
The Agency for Healthcare Research and Quality (AHRQ) 
defines the patient centered medical home model (PCMH) as 
an organization of primary care that delivers the core 
function of primary health care.  These 5 functions include:  
1) comprehensive care, 2) patient-centered, 3) coordinated 
care, 4) accessible services, and 5) quality and safety.1  
Creating a team of diverse care providers to meet the needs 
of the patient is commonly done in large organizations.2  
Access to rural primary care services continues to be a 
challenge for those with chronic diseases.  While 25% of the 
U.S. population live in rural communities, only 10% of general 
practice physicians work in these rural communities.3  An 
American Academy of Nurse Practitioners 2009-2010 national 
survey showed that 17.8% of ARNPs practice in a rural 
setting.4 Smaller practices in rural settings can deliver similar 
levels of comprehensive care by linking themselves and their  
 
 
Corresponding author: Christopher P. Parker, PharmD, 
BCACP, College of Pharmacy, University of Iowa, 115 S. Grand 
Ave., S533 PHAR, Iowa City, IA 52242. Phone: 319-384-4127. 
Fax: 319-384-1728. E-mail: christopher-parker@uiowa.edu   
patients to providers and services available in their  
communities.1 
 
Hypertension is a chronic disease that is poorly controlled in 
the United States.5,6  According to the CDC, 1 in 3 Americans, 
67 million people, have hypertension.  Of those, less than 
half, 47%, are controlled.7  One theory as to why 
hypertension is so poorly controlled despite many patient-
physician interactions is time constraints during office visits 
that don’t allow for the physician to address hypertension 
when it is not the patient’s chief complaint.8  Previous 
literature has also suggested that medications are not 
optimally used when blood pressure is uncontrolled.9,10 
 
Studies have found that while education is important, used 
alone it is not an effective approach in lowering 
BP.11,12Physician-pharmacist team-based care has been 
utilized as a much more intensive approach to identify, 
manage and control hypertension.13  According to an analysis 
of clinical trials conducted by the Stanford-UCSF Evidence-
based Practice Center for the AHRQ, interdisciplinary 
management of hypertension was one of the most effective 
strategies.12 
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A review of studies examining the incorporation of 
pharmacists into ambulatory and family medicine clinics has 
shown improvement in patient care.14  Community 
pharmacists in a chain pharmacy setting also have been 
shown to improve BP control and to increase adherence to 
medications.15,16The additional steps of having the 
community pharmacist monitor BP, educate patients about 
lifestyle changes and the importance of medication 
adherence, and making specific medication related 
recommendations to the primary care provider (PCP) are 
thought to lead to the improvement in blood pressure 
control.  
 
The purpose of this study was to determine if a team-based 
collaborative model between an ARNP and a community 
pharmacist in a rural setting would be effective at managing 
uncontrolled HTN. 
 
Setting and Practice Description 
The project was conducted at Mercy Family Pharmacy in 
Cascade, IA, a rural community pharmacy located in the same 
building as a family medicine clinic, though under separate 
ownership.  Pharmacists at the site routinely provide clinical 
pharmacy services, including an anticoagulation clinic with a 
collaborative practice agreement, immunization 
administration, medication therapy management (MTM), 
blood pressure monitoring, cholesterol screening, and 
diabetes education.  The pharmacy employs two pharmacists, 
with one pharmacist staffing daily along with two pharmacy 
technicians and an average daily volume of 150-200 
prescriptions.   
 
The family medicine clinic employs one full-time ARNP, one 
part-time ARNP and one part-time MD, with only one 
provider seeing patients each day.  The total number of 
patients seen by these providers averages 30 patients per 
day, with 60% of the patient visits being for acute conditions.  
The patient population ranges from newborn and pediatric to 
geriatric. 
 
Methods 
At the start of the project, the two pharmacists and the ARNP 
participated in a face-to-face 60-minute team building session 
during which they discussed their team approach. The 
approach was to translate a proven physician-pharmacist 
team management within-clinic model in a community 
pharmacy where the team members were not working within 
a clinic for the same employer.  Decisions were made on how 
to identify patients for team care, practitioner roles, and 
communication processes.  The team completed a team 
worksheet that described their decisions for these topics 
(Table 1). A copy of the completed team worksheet was given 
to each team member for future reference.  Within one 
month of starting the hypertension clinic, the second ARNP 
and MD began referring patients for the pharmacist to 
manage.  These two individuals did not participate in the 
initial team building session, but were briefed on specifics.  
Data from patients referred by the MD and second ARNP are 
not included in this manuscript.  
 
A toolkit document on team management of BP was used to 
support establishing and maintaining the provider-pharmacist 
team.  Both a printed version and an electronic version (E.g. 
pdf files) of the toolkit were given to the practitioners during 
the team building session. Topics addressed in the toolkit 
included: project team contact information, description of 
the team model to BP management, evidence supporting the 
team approach, goals for the project, references to the 
Seventh Report of the Joint National Committee on 
Prevention, Detection, Evaluation, and Treatment of High 
Blood Pressure (JNC7)17, detailed suggestions for team 
management of BP, sample interventions to address 
uncontrolled BP, and instructions for proper measurement of 
BP. In addition, numerous one-page documents suitable for 
patient education (E.g. diet, home BP monitoring) were 
included in the materials.18 
 
Patients were identified by multiple methods.  First, all 
patients newly diagnosed with hypertension by the ARNP 
were referred to the pharmacy for follow-up monitoring.  
Second, poorly controlled patients, identified by the ARNP as 
patients who have had multiple follow-up visits to address 
their hypertension, were referred to the pharmacist.  Third, 
patients already diagnosed with hypertension who filled a 
new hypertensive medication prescribed by the ARNP at the 
pharmacy were identified by the pharmacist and enrolled in 
the team-based hypertension management clinic. 
 
Each pharmacist reviewed proper blood pressure technique 
and was trained to measure BP using standardized 
guidelines.19  BP was measured 3 times using an automated 
Omron BP-785 device.  The second and third BP values at 
each visit were averaged and used to determine the BP value.  
Patients were asked if they had any blood work done in the 
last 5 days or had a mastectomy, and if so, the arm opposite 
where blood was taken from or opposite side the 
mastectomy occurred was used.  It was decided prior to 
seeing any patients that since the pharmacist had read-only 
access to the electronic medical record (EMR), the pharmacist 
would record BP readings for each patient in a Microsoft 
Excel spreadsheet and provide these data to the clinic nurse 
on a weekly basis so she could enter the readings into the 
EMR in order to improve continuity of care. 
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Each patient enrolled in the team-based hypertension 
management clinic received an initial visit with the 
pharmacist ranging from 30-45 minutes per session.  During 
this visit, the pharmacists educated the patients on proper 
home blood pressure monitoring technique as well as 
measured the circumference of the patient’s arm to 
determine the appropriate cuff size.  The pharmacist 
discussed the importance of blood pressure control, risks 
associated with uncontrolled blood pressure, how their blood 
pressure medications work, possible adverse effects from 
their medications, how to take their medications, and lifestyle 
modifications like physical activity and the Dietary 
Approaches to Stop Hypertension (DASH) eating plan.20 
Patients were scheduled for a 2 week follow-up BP check at 
the conclusion of the initial visit using a Microsoft Outlook 
shared calendar accessible by the pharmacists and 
technicians.  Patients were encouraged to check their BP daily 
and to keep a log of the readings, the date taken, the time of 
day taken, and any pertinent information that may have 
affected their readings (E.g. missed medication doses or 
taking over-the-counter medications).  If the patient did not 
have a home BP monitoring device, model suggestions were 
made by the pharmacist and in some cases, home BP 
monitors were purchased from the pharmacy after the initial 
visit. 
 
All patients in the team-based hypertension management 
clinic were documented in the pharmacy dispensing software 
program using a template created by one of the pharmacists 
to identify them as a hypertension patient as well as utilizing 
the prescription refill option as a reminder of Microsoft 
Outlook scheduled follow-up BP check appointments.  The 
technician would put the “refill” in as a pending order to be 
processed the date prior to the appointment date.  The 
technician would then call the patient the day prior to their 
follow-up appointment as a reminder. 
 
At the 2 week follow-up appointment the pharmacist took 
the patient’s BP, and if a patient’s BP was not below goal, 
assessed as to why the appropriate reduction in BP was not 
obtained.  If it was determined the patients were adherent to 
their medications and they were implementing the suggested 
lifestyle changes, then the pharmacist recommended to the 
PCP titration of BP medication doses, or the addition of an 
additional BP medication if already at maximum doses.  
Patients were seen at 2 week intervals until goal BP was 
achieved.  These follow-up visits ranged from 5-15 minutes in 
length. 
 
 
 
Results 
All BP values used for analysis were extracted from the clinic 
EMR.  Initial BP values were those readings documented by 
the ARNP prior to referring a patient to the pharmacist.  Final 
BP values were those in the EMR closest to the April 2014 end 
date.  A total of 13 patients with uncontrolled hypertension, 
five of who were newly diagnosed, were referred to the 
team-based hypertension management clinic by the ARNP 
starting February 2013, with the final patient referred March 
2014.  The initial average SBP and DBP readings were 157 
mmHg and 98 mmHg, respectively.  Following the 
intervention, the average SBP was 133 mmHg and DBP was 
86 mmHg, a decrease of 24 mmHg and 12mmHg respectively. 
Each patient's initial and final BP, number of visits with the 
pharmacists, and if they reached BP goal are shown in Table 
2.  The pharmacists made 21 recommendations (dose 
increase (11), add a medication (6), change a medication (2), 
and addition of an adherence tool (2)), 100% of which were 
accepted by the ARNP. 
 
The number of visits each patient had with the pharmacist 
ranged from two to 22.  The patient with 22 visits had a 
weekly medbox filled by the pharmacy, due to his history of 
non-adherence and multiple uncontrolled chronic disease 
states.   The next highest number of visits with the 
pharmacist was nine. 
 
Discussion 
The team-based collaborative model between the ARNP and 
pharmacists was implemented in a rural community 
pharmacy to manage hypertension.  The success rate of this 
program is consistent with prior studies looking at a similar 
intervention in rural and urban community pharmacies.6,21 A 
system was established supporting the team-based approach.  
The system components included an effective process for 
identifying and referring patients, clear roles for the team 
members, trusting relations between the team members, and 
effective communication procedures.  Given the growth of 
ARNPs in rural settings, these findings support the use of 
ARNP-community pharmacist team-based management as a 
viable approach for improving BP control for rural patients. 
Another factor making the team-based collaborative model a 
more effective approach to managing HTN is the expertise 
pharmacists have optimizing medication regimens.  Studies 
have shown that pharmacists improve BP control through 
medication intensification.13 Addressing adherence also 
played a critical role in helping patients achieve goal BP.  The 
pharmacist would determine, though interviews with the 
patient, whether poor adherence was intentional or 
unintentional.   If unintentional, adherence aids would be 
recommended.  If intentional, the pharmacist would work 
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with the patient identifying methods to overcome the 
barriers. 
 
Additional factors that contributed to the success of this 
particular project included pharmacist access to the EMR, an 
established collaborative relationship with the ARNP, and the 
participation of the nurses in the clinic to facilitate 
communication between the pharmacist and the ARNP.  It 
has been common practice for the pharmacist to provide 
curbside consults for the ARNP multiple times per day leading 
to a collaborative relationship.  Since the number of 
healthcare practitioners in rural settings is limited, PCPs and 
community pharmacists should be able to establish working 
relationships in order to increase access to healthcare for 
patients in these communities.  Such relationships provided 
an important platform to support the team management of 
HTN in this case.  While this specific type of relationship may 
not be needed to implement a clinical pharmacy service in a 
community pharmacy setting, the development of 
relationships with other healthcare providers in the 
community may enhance the success of such a service. 
 
This project was funded through a grant from the Iowa 
Department of Public Health to help defer some of the costs 
associated with a team-based model of $1000 each for the 
clinic and the pharmacy.  These costs primarily included the 
team building session and additional time spent by the ARNP 
and pharmacist collaborating on the hypertensive patients.  
No fees were available for the pharmacy visits.  In many rural 
clinic settings it would not be financially feasible to employ a 
full-time clinical pharmacist, but a solution could be for one 
clinical pharmacist to share his/her time across multiple 
locations.  
  
Future research is needed to determine if a team-based 
approach for managing hypertension between an ARNP and 
community pharmacist can reduce both SBP and DBP.  In 
order to eliminate the possibility of cross-contamination of 
the intervention by adding a control group at the same clinic, 
a cluster-randomized study design, where clinics are 
randomized as opposed to individual subjects, would be 
preferred.  A larger sample size should also be considered to 
help determine what impact the pharmacist intervention has 
on lowering BP. 
 
Limitations 
This project had limitations.  First, the ability to expand this 
model to other settings may be difficult since the pharmacists 
had access to the EMR.  However, with improving health 
information exchange it is likely more pharmacists will have 
access to EMRs in the future.  Also, the pharmacists had an 
existing collaborative relationship with the ARNP, including a 
collaborative practice agreement to independently manage 
anticoagulation.  There was also no control group to compare 
the results to and it is unknown if the recommendations the 
pharmacists made to the ARNP impacted her prescribing 
habits for other patients in the clinic.  We are unsure what 
component of the intervention decreased BP.  In addition to 
the pharmacist recommendations for medication and lifestyle 
changes, it is possible it could have been increased 
frequencies of BP checks or some other confounding factor.  
Finally, no statistical testing was performed to analyze the 
data.  Instead, average BPs have been reported, which likely 
tempers the conclusion of the pharmacists’ impact on 
lowering BP. 
 
Unfortunately, the amount of time spent by each pharmacist 
per each patient interaction was not documented until 6 
months into the project.  This information would help to 
determine if the intervention could be cost effective and a 
viable business model.  The pharmacists were not able to 
submit reimbursement claims for their time to the patient’s 
insurance companies as this was not a covered service.  Thus, 
it is difficult to determine the cost-effectiveness of the team-
based care to the pharmacy. 
 
Conclusions 
A team-based collaborative approach to managing 
hypertension may be an effective way to lower BP in a rural 
community pharmacy setting.  ARNP-pharmacist team-based 
management models are unique since most clinics utilize 
physician-pharmacist models for team-based management of 
chronic disease.  In addition, the core functions of the PCMH 
model can be delivered in a small family medicine practice.  
Outlining expectations for each team member helps create a 
workflow supporting the team-based approach.  An existing 
collaborative relationship with the PCP as well as access to 
the EMR are additional resources that can add to the success 
of the service. 
 
 
  
Original Research PRACTICE-BASED RESEARCH 
 
http://z.umn.edu/INNOVATIONS                      2015, Vol. 6, No. 2, Article 202                          INNOVATIONS in pharmacy   5 
 
References 
1. AHRQ. Defining the PCMH 
http://pcmh.ahrq.gov/page/defining-pcmh. 
2. Bodenheimer T, Wagner EH, Grumbach K. Improving 
primary care for patients with chronic illness. JAMA. 
2002;288(14):1775-1779. 
3. W.M. W, K. N, R. S, et al. Recruitment and Retention 
of a Quality Health Workforce in Rural Areas: A series 
of Policy Papers on The Rural Health Careers Pipeline 
Number 1: Physicians. Natinal Rural Health 
Association Issue Paper; November 2006 2006. 
4. The National Health Service Corps: Building Healthy 
Communities by Supporting Qualified Nurse 
Practitioners and Physician Assistants In: SERVICES 
USDOHAH, ADMINISTRATION HRAS, eds2014. 
5. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. 
Prevalence, awareness, treatment, and control of 
hypertension among United States adults 1999-
2004. Hypertension. 2007;49(1):69-75. 
6. Robinson JD, Segal R, Lopez LM, Doty RE. Impact of a 
pharmaceutical care intervention on blood pressure 
control in a chain pharmacy practice. Ann 
Pharmacother. 2010;44(1):88-96. 
7. CDC. Vital signs: awareness and treatment of 
uncontrolled hypertension among adults--United 
States, 2003-2010. MMWR. Morbidity and mortality 
weekly report. 2012;61:703-709. 
8. Ostbye T, Yarnall KS, Krause KM, Pollak KI, Gradison 
M, Michener JL. Is there time for management of 
patients with chronic diseases in primary care? Ann. 
Fam. Med. 2005;3(3):209-214. 
9. Berlowitz DR, Ash AS, Hickey EC, et al. Inadequate 
management of blood pressure in a hypertensive 
population. N Engl J Med. 1998;339(27):1957-1963. 
10. Oliveria SA, Lapuerta P, McCarthy BD, L'Italien GJ, 
Berlowitz DR, Asch SM. Physician-related barriers to 
the effective management of uncontrolled 
hypertension. Arch Intern Med. 2002;162(4):413-
420. 
11. Goldstein MK, Lavori P, Coleman R, Advani A, 
Hoffman BB. Improving adherence to guidelines for 
hypertension drug prescribing: cluster-randomized 
controlled trial of general versus patient-specific 
recommendations. Am J Manag Care. 
2005;11(11):677-685. 
12. Walsh JM, McDonald KM, Shojania KG, et al. Quality 
improvement strategies for hypertension 
management: a systematic review. Med Care. 
2006;44(7):646-657. 
13. Carter BL, Bergus GR, Dawson JD, et al. A cluster 
randomized trial to evaluate physician/pharmacist 
collaboration to improve blood pressure control. J 
Clin Hypertens (Greenwich). 2008;10(4):260-271. 
14. Carter BL, Helling DK. Ambulatory care pharmacy 
services: the incomplete agenda. Ann Pharmacother. 
1992;26(5):701-708. 
15. Park JJ, Kelly P, Carter BL, Burgess PP. 
Comprehensive pharmaceutical care in the chain 
setting. J Am Pharm Assoc (Wash). 
1996;NS36(7):443-451. 
16. Svarstad BL, Kotchen JM, Shireman TI, et al. 
Improving refill adherence and hypertension control 
in black patients: Wisconsin TEAM trial. Journal of 
the American Pharmacists Association : JAPhA. 
2013;53(5):520-529. 
17. JNC 7. The Seventh Report of the Joint National 
Committee on Prevention, Detection, Evaluation, and 
Treatment of High Blood Pressure. Bethesda 
MD2004. 
18. Doucette WR, Lickteig, C, Veach, S, Carter, B. L. 
Fostering Provider-Pharmacist Team Management of 
Hypertension in the Community. In: Health IDoP, ed. 
Final Report to the Iowa Dept of Public Health.2013. 
19. Pickering TG, Hall JE, Appel LJ, et al. 
Recommendations for blood pressure measurement 
in humans and experimental animals: Part 1: blood 
pressure measurement in humans: a statement for 
professionals from the Subcommittee of Professional 
and Public Education of the American Heart 
Association Council on High Blood Pressure 
Research. Hypertension. 2005;45(1):142-161. 
20. Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on 
blood pressure of reduced dietary sodium and the 
Dietary Approaches to Stop Hypertension (DASH) 
diet. DASH-Sodium Collaborative Research Group. N 
Engl J Med. 2001;344(1):3-10. 
21. Carter BL, Barnette DJ, Chrischilles E, Mazzotti GJ, 
Asali ZJ. Evaluation of hypertensive patients after 
care provided by community pharmacists in a rural 
setting. Pharmacotherapy. 1997;17(6):1274-1285. 
 
 
 
 
 
 
 
Original Research PRACTICE-BASED RESEARCH 
 
http://z.umn.edu/INNOVATIONS                      2015, Vol. 6, No. 2, Article 202                          INNOVATIONS in pharmacy   6 
 
 
Table 1. Team building worksheet 
Pr
es
cr
ib
er
’s
  
Ro
le
s 
• Coordinate hypertension treatment 
• Refer patients to pharmacist - prn 
• Respond to pharmacist recommendations 
 
Ph
ar
m
ac
is
t’
s 
 
Ro
le
s 
• Generate initial report of HTN patients 
• Conduct BP visits with patients 
• Communicate with physicians - prn 
• Patient education – prn 
• Charting/Log 
 
Pa
ti
en
t 
 Id
en
ti
fic
at
io
n • Pharmacy generates initial list of common patients with HTN diagnosis 
• Physician identifies patients with new HTN diagnosis 
• Determine BP control status  
Co
m
m
un
ic
at
io
n 
St
ra
te
gi
es
 
• Faxes  - Email – Face to Face – Phone – EMR’s 
 
 
 
 
Pa
ti
en
t 
Fo
llo
w
-u
p 
Sc
he
du
le
 •  
•   
•   
•  
Te
am
  
Fo
llo
w
-u
p 
Se
ss
io
n 
• Recommended in 6-8 weeks 
• Debrief and comment 
• Implement modifications   
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Table 2. Initial and final BP readings and total visits with pharmacist 
Subject Initial BP (mmHg) Final BP (mmHg) Reached goal BP 
(*=yes) 
Total visits with 
pharmacist 
1 136/90 122/82 * 2 
2 152/94 150/80  4 
3 135/91 148/78  3 
4 158/89 129/93 * 3 
5 131/92 129/86 * 22 
6 129/92 142/84  4 
7 163/100 114/68 * 4 
8 141/95 125/100  9 
9 165/109 107/72 * 6 
10 158/98 127/94  5 
11 168/100 144/82 * 3 
12 161/97 134/90  1 
13 155/110 158/103  4 
 
 
